Flash e-reader

 Go to e-reader chapter








Table 12.14

Unadjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,777 92.5% 0.5% 2,777 83.0% 0.7% 7,599 54.1% 0.7% 12,189 28.8% 0.7%
Lung Diagnosis Group Group A: Obstructive Lung Disease 989 93.2% 0.8% 989 84.0% 1.2% 3,151 55.4% 1.1% 5,706 25.8% 1.0%
Group B: Pulmonary Vascular Disease 115 85.2% 3.3% 115 80.0% 3.7% 311 50.0% 3.7% 541 38.5% 2.9%
Group C: Cystic Fibrosis or Immunodef. Disorders 372 96.0% 1.0% 372 86.6% 1.8% 1,101 56.8% 1.8% 1,808 39.0% 1.7%
Group D: Restrictive Lung Disease 1,232 91.7% 0.8% 1,232 81.2% 1.1% 2,861 52.1% 1.3% 3,825 26.2% 1.6%
Group E: Age Less Than 12 25 92.0% 5.4% 25 84.0% 7.3% 93 51.7% 6.2% 178 38.5% 4.9%
Other Diagnosis 44 90.9% 4.3% 44 88.6% 4.8% 82 59.6% 8.2% 131 38.7% 7.0%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.